Genentech Inc. and U.S. regulators have added a warning about the risk of a certain type of anemia with the company's Raptiva drug, used to treat psoriasis.
In a letter to doctors, the company and the Food and Drug Administration, warned about the risk of serious infection and decreased blood platelets that could be associated with consumption of the medication
